| Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers (NCT04117958) | Amgen | 2020-01-20 |
| The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia (NCT04013555) | University of Maryland, Baltimore | 2020-01-20 |
| VNRX-7145 SAD/MAD Safety and PK in Healthy Adult Volunteers (NCT04243863) | Basilea Pharmaceutica | 2020-01-20 |
| Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting (NCT05287633) | University of Monastir | 2020-01-20 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor (NCT04192344) | Abbisko Therapeutics Co, Ltd | 2020-01-20 |
| Inorganic Nitrate: Sex Differences in Muscle Contractile Function and Efficiency (NCT04588740) | University of Virginia | 2020-01-20 |
| Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects (NCT04233814) | Rein Therapeutics | 2020-01-20 |
| Umbilical Cord Serum Versus Conventional Eyedrops (NCT04217785) | National University of Malaysia | 2020-01-20 |
| A Clinical Trial of Breast Cancer Neo-adjuvant Therapy Based on Molecular Pathway in FUSCC (NCT04215003) | Fudan University | 2020-01-20 |
| Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain (NCT04238676) | Persica Pharmaceuticals Ltd | 2020-01-20 |
| Molecular Imaging of Lymphoma Using Labeled Technetium-99m 1-Thio-D-Glucose (NCT04292626) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2020-01-19 |
| A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects (NCT04238195) | Spero Therapeutics | 2020-01-19 |
| Single Dose Crossover Comparative Bioavailability Study of Bupropion Hcl MR Tablet 300mg (NCT05160090) | Alembic Pharmaceuticals Ltd. | 2020-01-18 |
| Soft Tissue Graft Versus Acellular Dermal Matrix in Preservation of Buccal Plate of Bone (NCT06229561) | Faculty of Dental Medicine for Girls | 2020-01-18 |
| A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants (NCT04235270) | Janssen Research & Development, LLC | 2020-01-17 |
| A Study to Evaluate the Effects of Loperamide (JNJ-289679) on Electrocardiogram Intervals in Healthy Adult Participants (NCT04225078) | Janssen Research & Development, LLC | 2020-01-17 |
| A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration (NCT04201457) | Pediatric Brain Tumor Consortium | 2020-01-17 |
| Study of Intrahepatic Arterial Infusion of TG6002 in Combination With 5-FC in Patients With Metastatic Colorectal Cancer (NCT04194034) | Transgene | 2020-01-17 |
| Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer (NCT04191421) | Emory University | 2020-01-17 |
| A Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986263 in Participants With Varying Degrees of Liver Impairment (NCT04225936) | Bristol-Myers Squibb | 2020-01-16 |
| A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer (NCT04148937) | Eli Lilly and Company | 2020-01-16 |
| A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients (NCT04916756) | Peking Union Medical College Hospital | 2020-01-16 |
| A Study to Assess the Effect AZD4831 in Japanese and Chinese Healthy Volunteers (NCT04232345) | AstraZeneca | 2020-01-16 |
| A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin (NCT04059588) | Rockefeller University | 2020-01-16 |
| A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma (NCT05950165) | Cho Pharma Inc. | 2020-01-15 |
| A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function (NCT04241835) | Epizyme, Inc. | 2020-01-15 |
| A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor (NCT04747964) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2020-01-15 |
| Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol (NCT03997370) | NRG Oncology | 2020-01-15 |
| Pharmacokinetics of Rivaroxaban After Bariatric Surgery (NCT04180436) | University Hospital, Brest | 2020-01-15 |
| A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney Function (NCT04209049) | Novo Nordisk A/S | 2020-01-15 |
| Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome (NCT04093531) | University of Rochester | 2020-01-15 |
| Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults (NCT04142086) | Sanofi Pasteur, a Sanofi Company | 2020-01-15 |
| Venetoclax and Lintuzumab-Ac225 in AML Patients (NCT03867682) | Actinium Pharmaceuticals | 2020-01-15 |
| A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL) (NCT04171791) | Yale University | 2020-01-15 |
| Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) (NCT04020575) | Minerva Biotechnologies Corporation | 2020-01-15 |
| A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Diffuse Non-Hodgkin Lymphoma (NCT04232826) | Juventas Cell Therapy Ltd. | 2020-01-15 |
| AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications. (NCT04240314) | Megan Waldrop | 2020-01-15 |
| Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia (NCT03989466) | M.D. Anderson Cancer Center | 2020-01-15 |
| A 2-part Study to Investigate the Effect of Macitentan in Healthy Male Participants (NCT04211272) | Actelion | 2020-01-14 |
| the Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose Ascending (NCT04502901) | Suzhou Kintor Pharmaceutical Inc, | 2020-01-14 |
| Hepatic Impairment Study for Lorlatinib in Cancer Patients (NCT03726333) | Pfizer | 2020-01-14 |
| To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and Women (NCT04281342) | Idorsia Pharmaceuticals Ltd. | 2020-01-14 |
| Study to Evaluate the Pharmacodynamics After Single Oral Dosing of Tegoprazan, EAPA115 and RAPA115 in Healthy Volunteers (NCT04231136) | HK inno.N Corporation | 2020-01-14 |
| Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours (NCT04236414) | AstraZeneca | 2020-01-14 |
| Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects (NCT04746287) | Chong Kun Dang Pharmaceutical | 2020-01-14 |
| Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults (NCT04227210) | Meissa Vaccines, Inc. | 2020-01-14 |
| Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid (NCT04309656) | Global Alliance for TB Drug Development | 2020-01-14 |
| A Phase 1 Study to Evaluate Pregabalin and Acetaminophen in Healthy Volunteers (NCT04265456) | Nevakar, Inc. | 2020-01-14 |
| Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment (NCT04256707) | Karyopharm Therapeutics Inc | 2020-01-14 |
| Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b (NCT05401305) | St. Petersburg Research Institute of Vaccines and Sera | 2020-01-14 |
| A Study to Assess the Amount of Drug Levels in Blood and Safety of AZD5718 Formulations in Healthy Volunteers (NCT04210388) | AstraZeneca | 2020-01-14 |
| Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia (NCT04172844) | Medical College of Wisconsin | 2020-01-13 |
| Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions (NCT04318535) | GlaxoSmithKline | 2020-01-13 |
| Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19 (NCT04390152) | BioXcellerator | 2020-01-13 |
| Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis (NCT04211415) | Daiichi Sankyo Co., Ltd. | 2020-01-13 |
| Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects (NCT04204629) | Hanmi Pharmaceutical Company Limited | 2020-01-13 |
| Levels of Matrix Metalloproteinase-8 After Intrapocket Treatment in Moderate Periodontitis Patients. (NCT04605289) | Alexandria University | 2020-01-13 |
| Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe) (NCT04097561) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-01-13 |
| Evaluating the Safety and Immunogenicity of HIV-1 BG505 SOSIP.664 gp140 With TLR Agonist and/or Alum Adjuvants in Healthy, HIV-uninfected Adults (NCT04177355) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-01-13 |
| Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855 (NCT04200573) | Theravance Biopharma | 2020-01-13 |
| Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma (NCT04635735) | Memorial Sloan Kettering Cancer Center | 2020-01-12 |
| Clinical Trial on Pharmacokinetic and Tolerability of AP701 (NCT04708795) | CannaXan GmbH | 2020-01-11 |
| Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product (NCT04422028) | Laboratorios Andromaco S.A. | 2020-01-11 |
| Tenofovir Rectal Douche to Prevent HIV Transmission (NCT04016233) | Johns Hopkins University | 2020-01-10 |
| Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients (NCT04268563) | Shahid Beheshti University of Medical Sciences | 2020-01-10 |
| A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer (NCT04227041) | Qingdao Zhixin Health Technology Co., Ltd. | 2020-01-10 |
| CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies (NCT04088864) | Kara Lynn Davis | 2020-01-10 |
| Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution (NCT04177082) | Cornea Associates of Texas | 2020-01-10 |
| Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant (NCT03537599) | Sumithira Vasu | 2020-01-10 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects (NCT04146805) | Blade Therapeutics | 2020-01-10 |
| A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants (NCT04178733) | Eli Lilly and Company | 2020-01-10 |
| Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma (NCT04176016) | OncoTherapy Science, Inc. | 2020-01-10 |
| A Study of CS3005 in Advanced Solid Tumors (NCT04233060) | CStone Pharmaceuticals | 2020-01-10 |
| LITT and Pembrolizumab in Recurrent Brain Metastasis (NCT04187872) | University of Florida | 2020-01-10 |
| Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts (NCT04186650) | Institut National de la Santé Et de la Recherche Médicale, France | 2020-01-10 |
| A Phase 1, Open-Label, PET Study of T2310 & BPN14770 (NCT04044781) | Tetra Discovery Partners | 2020-01-10 |
| A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants (NCT04223349) | Janssen Research & Development, LLC | 2020-01-10 |
| A Trial to Evaluate the Effect of Food on LEO 152020 (NCT04203836) | JW Pharmaceutical | 2020-01-09 |
| A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink. (NCT04194645) | Boehringer Ingelheim | 2020-01-09 |
| Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies (NCT04033159) | Dynacure | 2020-01-09 |
| Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors (NCT04126590) | Changchun Intellicrown Pharmaceutical Co. LTD | 2020-01-09 |
| Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma (NCT03995017) | University of Kansas Medical Center | 2020-01-09 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Bioavailability, and Food-effects of EA1080 in Healthy Caucasian and Japanese Male Participants (NCT04223960) | EA Pharma Co., Ltd. | 2020-01-09 |
| A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004 (NCT04277910) | Xi'an Biocare Pharma Ltd. | 2020-01-09 |
| Safety, Tolerability and Pharmacokinetics of HSK21542 in Healthy Volunteers (NCT04213196) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2020-01-09 |
| Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL (NCT04260022) | Ascentage Pharma Group Inc. | 2020-01-09 |
| A Study of JNJ-70033093 and Digoxin in Healthy Participants (NCT04206488) | Janssen Research & Development, LLC | 2020-01-09 |
| A Study to Evaluate the Effect of Hepatic Impairment on JNJ-56136379 (NCT04208399) | Janssen Sciences Ireland UC | 2020-01-09 |
| A Study to Evaluate the Effect of Hepatic Impairment on JNJ-73763989 (NCT04208386) | Janssen Sciences Ireland UC | 2020-01-08 |
| Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis (NCT05200000) | TBF Genie Tissulaire | 2020-01-08 |
| Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma (NCT04201873) | Jonsson Comprehensive Cancer Center | 2020-01-08 |
| A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion (NCT04123886) | Sichuan Clover Biopharmaceuticals, Inc. | 2020-01-08 |
| A 2-Part Trial of CVL-751 in Subjects With Parkinson's Disease (NCT04295642) | Cerevel Therapeutics, LLC | 2020-01-08 |
| Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia (NCT03971799) | Center for International Blood and Marrow Transplant Research | 2020-01-08 |
| A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer (NCT04134312) | Bavarian Nordic | 2020-01-08 |
| The Effect of Chronic Pain on Delay Discounting in Methadone Patients (NCT04473950) | University of California, San Francisco | 2020-01-08 |
| A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults (NCT04148118) | BlueWillow Biologics | 2020-01-08 |
| A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients (NCT04024696) | Xynomic Pharmaceuticals, Inc. | 2020-01-08 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors (NCT04198818) | Haihe Biopharma Co., Ltd. | 2020-01-07 |
| A Phase I Study of LX-039 Tablets (NCT04097756) | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | 2020-01-07 |